The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Market Size Of The Psychedelic Drugs Market In 2026 And What Value Is Projected For 2030?
The psychedelic drugs market has experienced substantial expansion in recent times. Forecasts indicate its size will increase from $6.33 billion in 2025 to reach $7.37 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 16.4%. Historically, this growth can be ascribed to several factors, including a significant unmet requirement in depression therapy, initial academic investigations into psychedelics, instances of both underground and compassionate applications, the restricted effectiveness of traditional antidepressants, and an increasing understanding of mental health.
The psychedelic drugs market size is projected to experience swift expansion over the coming years. It is predicted to reach $13.67 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 16.7%. The anticipated growth during this period can be ascribed to factors such as regulatory approvals for medical applications, increasing adoption by psychiatrists, an expanding pipeline of indications, enhanced data on patient outcomes, and strategic alliances formed between biotech firms and healthcare providers. Key trends expected during the forecast timeframe encompass the expansion of psychedelic-assisted therapy programs, a rise in clinical trials targeting mental health indications, increased acceptance of alternative psychiatric treatments, clearer regulatory pathways for controlled substances, and growing investments from venture capital and pharmaceutical entities.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6345&type=smp
What Drivers Are Influencing The Psychedelic Drugs Market?
The rising prevalence of mental health conditions is anticipated to fuel the expansion of the psychedelic drugs market in the future. Mental illnesses encompass health issues characterized by changes in emotion, cognition, or behavior, including conditions such as distress and post-traumatic stress disorder. Psychedelic drugs are employed in the treatment of depression and post-traumatic stress disorder, and their consistent use contributes to a reduction in mental illnesses. For instance, in November 2023, the National Health Service, a UK-based government department, reported that in 2023, approximately one in five individuals aged 8 to 25 years were estimated to have a probable mental disorder, impacting 20.3% of 8 to 16-year-olds, 23.3% of 17 to 19-year-olds, and 21.7% of 20 to 25-year-olds. This increase in mental illness cases is consequently propelling the growth of the psychedelic drugs market.
What Are The Key Segments Of The Psychedelic Drugs Market?
The psychedelic drugs market covered in this report is segmented –
1) By Type: Lysergic Acid Diethylamide (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia
2) By Disease Indication: Depression, PTSD
3) By Origin: Natural, Synthetic
4) By Application: Treatment-Resistant Depression, Opiate addiction, Post- Traumatic Stress Disorder, Narcolepsy, Panic Disorders
5) By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Lysergic Acid Diethylamide (LSD): LSD Tablets, LSD Liquid, LSD Blotters
2) By Ketamine: Ketamine Infusion, Ketamine Nasal Spray, Ketamine Injectable
3) By Phencyclidine (PCP): PCP Powder, PCP Tablets, PCP Liquid
4) By Gamma Hydroxybutyric Acid (GHB): GHB Liquid, GHB Powder, GHB Capsules
5) By Salvia: Salvia Extract, Salvia Dried Leaves, Salvia Tinctures
What Key Trends Are Influencing The Development Of The Psychedelic Drugs Market?
Key companies in the psychedelic drugs market are concentrating on developing innovative solutions, such as pharmaceutical-grade psilocybin formulations, to improve therapeutic effectiveness, guarantee safety, and expand treatment possibilities for mental health disorders. A pharmaceutical-grade psilocybin formulation signifies psilocybin that is produced and standardized to meet pharmaceutical quality, thus ensuring consistent purity, potency, and safety for therapeutic applications. For instance, in September 2025, Optimi Health, an Australia-based psychedelic therapeutics company, introduced its natural psilocybin capsules in Australia for the treatment of TRD. With this launch, Optimi Health intends to provide a clinically supported treatment option for patients, broaden its presence in the Australian mental health market, and accelerate the adoption of psychedelic-assisted therapies.
Who Are The Leading Companies Operating In The Psychedelic Drugs Market?
Major companies operating in the psychedelic drugs market are Atai Life Sciences, Cybin Inc., Mind Medicine Inc., Compass Pathways, Seelos Therapeutics, Numinus Wellness Inc., GH Research, Revive Therapeutics, Havn Life Sciences, PharmaTher Holdings, Field Trip Health, Small Pharma, Incannex Healthcare, Optimi Health, NeonMind Biosciences, Entheon Biomedical, Mydecine Innovations Group, Red Light Holland, Eleusis, MAPS Public Benefit Corporation, Beckley Psytech, Awakn Life Sciences, Psygen Industries, Enveric Biosciences, Filament Health, Tactogen, Bexson Biomedical, BetterLife Pharma, Clairvoyant Therapeutics, Universal Ibogaine
Read the full psychedelic drugs market report here:
https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report
Which Regions Are Expected To Experience Rapid Expansion In The Psychedelic Drugs Market?
North America was the largest region in the psychedelic drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the psychedelic drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Psychedelic Drugs Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=6345&type=smp
Browse Through More Reports Similar to the Global Psychedelic Drugs Market 2026, By The Business Research Company
Psychedelic Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report
Neurological Disorder Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/neurological-disorder-drugs-global-market-report
Antipsychotic Drugs Market Report 2026
https://www.thebusinessresearchcompany.com/report/antipsychotic-drugs-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model